Liver function test to predict hepatic failure after liver resection - Expensive and without clinical relevance?;Funktionsdiagnostik vor Leberresektion - Teuer und Ohne Klinische Relevanz?

Zentralblatt fur Chirurgie

Volumn 132, Issue 4, 2007, Pages 267-273

  Kanzler, S ^a   Teufel, A ^a   Galle, P R ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Fuctional reserve; Hepatic resection; Indocyanine clearance; Liver failure; MEGX test

Indexed keywords

BILIRUBIN; DEETHYLLIDOCAINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDOCYANINE GREEN; LIDOCAINE;

ARTICLE; BLOOD; COMPARATIVE STUDY; DISEASE COURSE; HUMAN; LIVER; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TEST; LIVER REGENERATION; LIVER RESECTION; METHODOLOGY; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; PROGNOSIS; RISK FACTOR; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BILIRUBIN; DISEASE PROGRESSION; HEPATECTOMY; HUMANS; INDOCYANINE GREEN; LIDOCAINE; LIVER; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER REGENERATION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34548398424     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981197     Document Type: Article

References (65)

1. Abei M, Tanaka E, Tanaka N et al. Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity. J Gastroenterol 1995; 30: 478-484
2. Armuzzi A, Candelli M, Zocco MA et al. Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther 2002; 16: 1977-1996
3. Asano M, Ozawa K, Tobe T. Postoperative prognosis as related to blood ketone body ratios in hepatectomized patients. Eur Surg Res 1983; 15: 302-311
4. Behrns KE, Tsiotos GG, DeSouza NF et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998; 2: 292-298
5. Bruix J, Castells A, Bosch J et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.Gastroenterology 1996; 111: 1018-1022
6. Chijiiwa K, Watanabe M, Nakano K et al. Biliary indocyanine green excretion as a predictor of hepatic adenosine triphosphate levels in patients with obstructive jaundice. Am J Surg 2000; 179; 161-166
7. Clowes Jr GH, McDermott WV, Williams LF et al. Amino acid clearance and prognosis in surgical patients with cirrhosis. Surgery 1984; 96: 675-685
8. Didolkar MS, Fitzpatrick JL, Elias EG et al. Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet 1989; 169: 17-26
9. Dimick JB, Cowan Jr JA, Knol JA et al. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 2003; 138: 185-191
10. Ercolani G, Grazi GL, Calliva R et al. The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery. Surgery 2000; 127: 464-471
11. Fabris L, Jemmolo RM, Toffolo G et al. The monoethylglycinexylidide test for grading of liver cirrhosis. Aliment Pharmacol Ther 1999; 13: 67-75
12. Fan ST, Lai EC, Lo CM et al. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 1995; 130: 198-203
13. Froomes PR, Ghabrial H, Morgan DJ et al. The effect of oxygen supplementation on the arterial ketone body ratio in human cirrhosis. Digestion 2002; 66: 257-261
14. Fujioka H, Kawashita Y, Kamohara Y et al. Utility of technetium99m- labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve. J Clin Gastroenterol 1999; 28: 329-333
15. Furuya KN, Durie PR, Roberts EA et al. Glycine conjugation of paraaminobenzoic acid (PABA): a quantitative test of liver function. Clin Biochem 1995; 28: 531-540
16. Furuya KN, Durie PR, Roberts EA, Soldin SJ, Verjee Z, Yung-Jato L, Giesbrecht E, Ellis L. Glycine conjugation of para-aminobenzoic acid (PABA): a quantitative test of liver function. Clin Biochem 1995; 28: 531-540
17. 14C) aminopyrine breath test in liver disease. Gut 1978; 19: 40-45
18. Gill RA, Goodman MW, Golfus GR et al. Aminopyrine breath test predicts surgical risk for patients with liver disease. Ann Surg 1983; 198: 701-704
19. Hanazaki K, Wakabayashi M, Sodeyama H et al. Arterial ketone body ratio does not correlate with ischemic changes during major hepatectomy. Hepatogastroenterology 1998; 45: 145-149
20. Helmreich-Becker I, Schirmacher P, Denzer U, Hensel A, Meyer zum Buschenfelde KH, Lohse AW. Minilaparoscopy in the diagnosis of cirrhosis: superiority in patients with Child-Pugh A and macronodular disease. Endoscopy 2003; 35: 55-60
21. Hemming AW, Scudamore CH, Shackleton CR et al, Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 1992; 163: 515-518
22. Herold C, Heinz R, Niedobitek G et al. Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C. Liver 2001; 21: 260-265
23. Herold C, Heinz R, Radespiel-Troger M et al. Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity. Liver 2001; 21; 26-30
24. Huo TI, Wu JC, Lui WY et al. Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment. Am J Gastroenterol 2004; 99: 1479-1487
25. Huang YS, Chiang JH, Wu JC et al. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test. Am J Gastroenterol 2002; 97: 1223-1227
26. Ishikawa A, Fukao K, Tsuji K et al. Trimethadione tolerance tests for the assessment of feasible size of hepatic resection in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 1993; 8: 426-432
27. Jarnagin W, Gonen M, Fong Y et al. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade, Ann Surg 2002; 236: 397-407
28. Jaeck D, Bachellier P, Guiguet M et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 1997; 84: 977-980
29. Kawasaki S, Makuuchi M, Miyagawa S et al, Results of hepatic resection for hepatocellular carcinoma. World J Surg 1995; 19: 31-34
30. Kinoshita K, Ukikusa M, Iwaisako K et al. Preoperative assessment of hepatic function: utility of a new convenient two-compartment model analysis using galactosyl human serum albumin scintigraphy. J Gastroenterol Hepatol 2003; 18: 99-104
31. Kubo S, Nishiguchi S, Shuto T et al. Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma. Jpn J Cancer Res 1999; 90: 162-170
32. Kubota K, Makuuchi M, Kusaka K et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26: 1176-1181
33. Kudo M, Vera DR, Stadalnik RC et al. In vivo estimates of hepatic binding protein concentration: correlation with classical indicators of hepatic functional reserve. Am J Gastroenterol 1990; 85: 1142-1148
34. Kwon AH, Matsui Y, Ha-Kawa SK et al. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol 2001; 96: 541-546
35. Lau H, Man K, Fan ST et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997; 84: 1255-1259
36. Lebel S, Nakamachi Y, Hemming A et al. Glycine conjugation of paraaminobenzoic acid (PABA): a pilot study of a novel prognostic test in acute liver failure in children. J Pediatr Gastroenterol Nutr 2003; 36: 62-71
37. Lindner P, Cahlin C, Friman S, Hafstrom L, Rizell M, Olausson M. Treatment of patients with liver metastases from colorectal cancer. More patients can benefit from the treatmentl Lakartidningen 2003; 100: 2684-2688
38. Makuuchi M, Kosuge T, Takayama T et al. Surgery for small liver cancers. Semin Surg Oncol 1993; 9: 298-304
39. Merkel C, Gatta A, Zoli M et al. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci 1991; 36: 1197-1203
40. Minagawa M, Makuuchi M, Takayama T et al. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003; 238: 703-710
41. Miyagawa S, Makuuchi M, Kawasaki S et al, Changes in serum amylase level following hepatic resection in chronic liver disease, Arch Surg 1994; 129: 634-638
42. Mullin EJ, Metcalfe MS, Maddern GJ. How much liver resection is too much? Am J Surg 2005; 190: 87-97
43. Nagasue N, Kohno H, Tachibana M et al. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis. Ann Surg 1999; 229: 84-90
44. Nakamura H, Tanaka E, Kaneko M et al. The clinical importance of the trimethadione tolerance test as a method for quantitative assessment of hepatic functional reserve in patients with biliary atresia. J Clin Pharm Ther 2001; 26: 417-424
45. Oellerich M, Armstrong VW. The MEGX test: a tool for the real-time assessment of hepatic function. Ther Drug Monit 2001; 23: 81-92
46. Oellerich M, Burdelski M, Ringe B et al. Functional state of the donor liver and early outcome of transplantation. Transplant Proc 1991; 23: 1575-1578
47. Okamoto E, Kyo A, Yamanaka N et al. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984; 95: 586-592
48. Okochi O, Kaneko T, Sugimoto H et al. ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res 2002; 103: 109-113
49. Ozawa K, Ida T, Yamada T et al. Significance of glucose tolerance as prognostic sign in hepatectomized patients. Am J Surg 1976; 131: 541-546
50. Park GJ, Katelaris PH, Jones DB et al. Validity of the C-caffeine breath test as a noninvasive, quantitative test of liver function. Hepatology 2003; 38: 1227-1236
51. Redaelli CA, Dufour J, Wagner M et al. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 2002; 235: 77-85
52. Reding R, Wallemacq P, de Ville de Goyet J et al. The unreliability of the lidocaine/monoethylglycinexylidide test for assessment of liver donors. Transplantation 1993; 56: 323-326
53. 99mTc-GSA liver dynamic SPECT for the preoperative assessment of hepatectomy. Ann Nucl Med 2003; 17: 61-67
54. Sawamura T, Kawasato S, Shiozaki Y et al. Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats. Gastroenterology 1981; 81: 527-533
55. Scott NR, Stambuk D, Chakraborty J et al. Caffeine clearance and biotransformation in patients with chronic liver disease. Clin Sci 1988; 74: 377-384
56. Sitzmann JV, Greene PS. Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients. Ann Surg 1994; 219: 13-17
57. Schmidt LE, Ott P, Tygstrup N. Galactose elimination capacity as a prognostic marker in patients with severe acetaminophen-induced hepatotoxicity: 10 years' experience. Clin Gastroenterol Hepatol 2004; 2: 418-424
58. Stewart GD, O'Suilleabhain CB, Madhavan KK et al. The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol 2004; 30: 370-376
59. Suehiro T, Sugimachi K, Matsumata T et al. Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein. Cancer 1994; 73: 2464-2471
60. 99mTc-GSA SPECT and their usefulness in prognostic estimation after hepatectomy. J Nucl Med 2000; 41: 421-425
61. Takenaka K, Kanematsu T, Fukuzawa K et al. Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented? World J Surg 1990; 14: 123-127
62. Tanaka E, Inomata S, Yasuhara H. The clinical importance of conventional and quantitative liver function tests in liver transplantation. J Clin Pharm Ther 2000; 25: 411-419
63. Yamanaka N, Okamoto E, Kuwata K, Tanaka N, A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 1984; 200: 658-663
64. Yamanaka N, Okamoto E, Oriyama Tet al. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 1994; 219: 342-346
65. Yumoto Y, Umeda M, Ohshima K et al. Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine-pentaacetic acid galactosyl human albumin. Cancer Chemother Pharmacol 1994; 33: S1-S6